Clinical Trial at St. Michael's Hospital
Reduce Your Health Risks
In the fall of 2023 I participated in a clinical trial conducted by St. Michael’s Hospital in Toronto Canada. The research protocol was to test the efficacy of a red light transcranial and intranasal device. Other research studies on red light technologies concluded that the transcranial device showed significant promise to improve mild cognitive impairments and lower risk of dementia. The researchers confirmed through cognitive testing that I have mild cognitive impairments and thus was a good candidate for the clinical trial.
For many people having mild cognitive impairments is an age related condition. In reading about this condition I learned that 10 to 20% of people affected, develop Alzheimer’s. With this knowledge, I was a very eager participant in the trial and primed to learn all I could about reducing my risk of dementia.
Strengthening Your Health Span is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Reduce Your Health Risks
The clinical trial was sponsored by St. Michael’s Hospital (National Library of Medicine) in Toronto. Prior to my involvement in the Trial, I was hearing feedback from my friends and family about my forgetfulness and how I was often struggling to find the right word in my conversations.
I researched studies about short term memory loss and learned that 10 to 20 per cent of people with these symptoms develop dementia and Alzheimer’s. As I dug into the latest research, I came across a clinical trial study that was seeking participants who were exhibiting memory loss symptoms like mine. The umbrella term for these symptoms were called mild cognitive impairments.
Participating in the Clinical Trial was important to me because I wanted to do all I could to not develop dementia and possibly Alzheimer’s. Before joining the Trial, I researched many studies that identified redlight as a therapy for reducing the risk of developing dementia. In the Clinical Trial, participants wore a redlight headset with an intra-nasal device. The purpose of the study was to research the efficacy of an infra red device to address mild cognitive impairments.
I was eager to participate because I wanted to do all I could to not develop dementia or Alzheimer’s. Furthermore, by participating in the Trial I had an opportunity to contribute to the search for new therapeutic tools to reduce the risk of dementia. Through my participation in the clinical trial and curating videos published by leading edge scientists, I was establishing the foundation for publishing my Reduce Your Health Risk Newsletter on the Substack platform.
Below are Key Drivers I use as a guide for developmenting my Substack Newsletter.
My role as publisher is to curate the video presentations and supporting documents. I also share information that about my lived experience using therapeutic tools I use to increase my health span.
I see my role is to advocate to the public about health span devices and practices that enhance your your quality of life as you age.
I am a curator of video presentations published by scientists and researchers that can potentially encourage people to take steps that can improve quality of their life as they age.
I strive to curate quality research reports and productions created by researchers from Academia, Private sector, Institutions and Government.
My Newsletter’s Mission is to:
Bring hope to people at risk of developing dementia and chronic debilitating health conditions.
Encourage people to be open to learning about new tools for strengthening their health span.
Learn and share knowledge about new devices and protocols that can strengthen your health span.